WesBanco Bank’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Sell
22,300
-4,700
-17% -$266K 0.04% 287
2025
Q4
$1.12M Hold
27,000
0.03% 344
2025
Q3
$1.09M Hold
27,000
0.03% 355
2025
Q2
$702K Buy
+27,000
New +$651K 0.02% 407

Other funds holding CGON

WesBanco Bank's CGON Position: Q1 2026 in Review

WesBanco Bank reduced its CG Oncology (CGON) stake by 17% in Q1 2026, selling an estimated $266K and leaving 22,300 shares worth $1.51M. The position accounts for 0.04% of the portfolio, ranked #287.

WesBanco Bank first reported a position in CGON in Q2 2025 and has held it in 4 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • WesBanco Bank held 22,300 shares of CG Oncology worth $1.51M as of Q1 2026.
  • WesBanco Bank sold 4,700 CG Oncology shares in Q1 2026, an estimated $266K.
  • CG Oncology made up 0.04% of WesBanco Bank's portfolio in Q1 2026, its #287 holding.
  • WesBanco Bank first reported a position in CG Oncology in Q2 2025 and has held it in 4 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on WesBanco Bank's 13F filing for Q1 2026, filed 21 Apr 2026.